Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-349,400
Closed -$34.4M 1638
2025
Q2
$34.4M Sell
349,400
-110,000
-24% -$10.4M 0.38% 42
2025
Q1
$42.6M Sell
459,400
-610,900
-57% -$56.3M 0.41% 43
2024
Q4
$97.2M Buy
1,070,300
+1,014,200
+1,808% +$93.1M 0.92% 20
2024
Q3
$5.41M Sell
56,100
-38,900
-41% -$3.8M 0.09% 273
2024
Q2
$8.72M Buy
95,000
+30,000
+46% +$2.78M 0.13% 165
2024
Q1
$5.99M Buy
65,000
+15,000
+30% +$1.41M 0.09% 265
2023
Q4
$4.75M Buy
+50,000
New +$4.67M 0.06% 354
2021
Q4
Sell
-20,000
Closed -$2.98M 1567
2021
Q3
$2.98M Hold
20,000
0.03% 621
2021
Q2
$4.9M Hold
20,000
0.06% 370
2021
Q1
$5.29M Buy
+20,000
New +$5.64M 0.11% 231
2020
Q4
Sell
-15,000
Closed -$3.55M 948
2020
Q3
$3.55M Hold
15,000
0.08% 287
2020
Q2
$2.98M Buy
+15,000
New +$2.8M 0.1% 282

Other funds holding AMED

Caption Management's AMED Position: Q4 2021 in Review

Caption Management sold out of Amedisys (AMED) in Q4 2021, closing a stake of 10,000 shares — an estimated $1.49M sold.

Caption Management first reported a position in AMED in Q1 2021 and held it in 3 quarters. The position peaked at $1.49M in Q3 2021. 324 funds tracked by Wall St. Rank hold AMED as of Q4 2021.

  • Caption Management reported no remaining Amedisys position as of Q4 2021 after selling out during the quarter.
  • Caption Management sold 10,000 Amedisys shares in Q4 2021, an estimated $1.49M.
  • Caption Management first reported a position in Amedisys in Q1 2021 and held it in 3 quarters.
  • Caption Management's Amedisys position peaked at $1.49M in Q3 2021.
  • 324 funds tracked by Wall St. Rank held Amedisys as of Q4 2021.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.